Skip to main content

Table 1 MDM2 (rs2278744) polymorphism in patients with HPV and cervical lesions of low degree (LSIL) and high degree (HSIL) and healthy patients

From: MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives

 

Cases

Normal cytology

p-value; OR [95% C.I.]

 

Total SILa

LSILb

HSILc

Controld

Total SIL vs. C

LSIL vs. C

HSIL vs. C

HSIL vs. LSIL

SNP309 rs2278744

        

Alelles

        

T

265 (0.62)

165 (0.63)

100 (0.61)

95 (0.63)

Reference

Reference

Reference

Reference

G

156 (0.38)

95 (0.37)

61 (0.39)

55 (0.37)

0.80; 1.04 [0.71-1.54]

0.97; 0.99 [0.65-1.50]

0.67; 1.11 [0.70-1.75]

0.55; 1.14 [0.74-1.75]

Genotypes

        

TT

80 (0.37)

54 (0.42)

26 (0.30)

30 (0.40)

Reference

Reference

Reference

Reference

TG

105 (0.51)

57 (0.44)

48 (0.61)

35 (0.47)

0.83; 0.85 [0.48-1.49]

0.92; 1.11 [0.60-2.04]

0.33; 1.58 [0.80-3.13]

*0.11; 1.75 [0.95-3.20]

GG

27 (0.12)

19 (0.15)

8 (0.09)

10 (0.13)

0.83; 0.99 [0.43-2.28]

0.92; 0.95 [0.39-2.30]

0.33; 0.92 [0.32-2.69]

0.33; 0.92 [0.32-2.69]

  1. p < 0.05 – statistically significant.
  2. aSIL: Squamous intraepithelial lesions.
  3. bLSIL: Low-grade squamous intraepithelial lesions.
  4. cHSIL: High-grade squamous intraepithelial lesions.
  5. dC: Control - Normal cytology.
  6. *In overdominant model the risk to TG genotype was 1.81 (1.03-3.16, 95% CI).